The tumor lysis syndrome
- PMID: 21830982
- PMCID: PMC3740722
- DOI: 10.1056/NEJMc1106641
The tumor lysis syndrome
Erratum in
- N Engl J Med. 2011 Oct 27;365(17):1650
Comment on
-
The tumor lysis syndrome.N Engl J Med. 2011 May 12;364(19):1844-54. doi: 10.1056/NEJMra0904569. N Engl J Med. 2011. PMID: 21561350 Free PMC article. Review. No abstract available.
References
-
- Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–62. - PubMed
-
- McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation. 2001;104:2797–802. - PubMed
-
- Graham RC, Jr, Karnovsky MJ. The histochemical demonstration of uricase activity. J Histochem Cytochem. 1965;13:448–53. - PubMed
-
- Elitek (rasburicase) prescribing information, revised 2010. Sanofi-Aventis; Bridgewater, NJ: ( http://products.sanofi-aventis .us/elitek/elitek.html.)
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources